Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
Contents:; Trends in Head and Neck Cancer -- Treatment-Related Patient Outcomes for Head and Neck Cancer -- Quality of Life Implications in Head and Neck Cancer-- Mental Health in Head and Neck Cancer -- Disfigurement -- Impact of Communication and Swallowing Dysfunction -- The Impact of Nutrition …
Contents:
Contents:; 1. Head and neck cancer- the patient perspective -- 2. Physician assistants and nurse practitioners in head and neck surgery -- 3. Role of the speeh-language pathologist (SLP) in the head and neck cancer team -- 4. Oral and dental health in head and neck cancer patients -- 5. Imaging eva…
Contents:; Introduction: Impairment-based Cancer Rehabilitation by Type of Cancer -- Breast Cancer: Evidence along Continuum of Care-Prehab through Rehab -- Cancer of the Digestive Organs: Importance of Mobility for Motility -- Cancer of the Brain, Eye, and other Parts of the Central Nervous System…
http://www.demosmedpub.com/prod.aspx?prod_id=9781933864334
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; Part I: An Extraordinary Opportunity; Chapter 1. Creating a Learning Health Care System in Oncology; Chapter 2. Reducing Cancer Disparities Through Community Engagement: The Promise of Informatics; Chapter 3. Cancer Clinical Research: Enhancing Data Liquidity and Data Altruism; …
"Alternative medicine (AM) is popular; about 40% of the US general population have used alternative treatment in the past year, and in Germany this figure is around 70%. The global market is expected to reach nearly US $ 200 billion by 2025, with most of these funds coming directly out of consumers…